In this episode, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and why physicians should educate their patients about this type of inflammation.

This episode highlights findings from an investigative study exploring the molecular targeting of biologics for psoriasis, as well as discusses the interleukin(IL)-17 class of biologics, how this class compares to other classes such as IL-23 and TNFα, and how bimekizumab sets itself apart from other biologics in the pipeline for psoriasis.

This episode takes a deep dive in the recent delay in approval for multiple JAK inhibitor drugs for treatment of inflammatory skin conditions such as psoriasis and atopic dermatitis. Mark Lebwohl, MD, discusses the impact of the delay, as well as the benefits of JAK inhibitors for inflammatory skin diseases, and an outlook for the future of this drug class. 

In this episode, Assistant Editor Linda Stocum sits down with Jennifer Powers, MD, board certified dermatologist and associate professor of dermatology at the University of Iowa, to discuss her recent research exploring how diet and supplements affect patients with mild psoriasis.

In this episode, Alberto Pappo, MD, director, St. Jude Solid Tumor Division, discusses a registry he helped create aimed at helping physicians better understand pediatric melanoma called Molecular Analysis of Childhood MELanocytic Tumors (MACMEL).

In this episode, we provide an update on a story we broke regarding benzene contamination being detected in various sunscreens and after-sun care products. Now, Johnson & Johnson has conducted its own internal testing and is recalling 5 different aerosol sunscreen products from Neutrogena and Aveeno. Listen as Christopher Bunick, MD, explains what this means for the sun protection industry and the next steps for the FDA. 

The introduction of artificial intelligence into dermatology has been met with mixed emotions from the medical community. In this episode, Ade Adamson, MD, MPP, explains the benefits and detriments of the application, accuracy, and potential racial diagnostic bias.

This episode dives into how health care policy impacts gender and sexual minority patients, including exploring the Affordable Care Act (ACA) and Medicaid expansion, and identifying state and federal nondiscrimination protections that help defend equal access to health care for this patient population. 

 

This episode will highlight some breaking news coming out of the sun protection world with a report by Valisure, an independent lab dedicated to batch testing medications before they reach consumers, which found in a recent test that 78 different sunscreen and after-sun care products were contaminated with benzene, a potential carcinogen.

In this episode, we take a look back at what happened at the American 

Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), including exclusive interviews with two KOLs about their presentations regarding climate change and new data on biologics for psoriasis.